Squadron Capital Llc Sells 22,500 Shares of OrthoPediatrics (NASDAQ:KIDS) Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) major shareholder Squadron Capital Llc sold 22,500 shares of the stock in a transaction on Wednesday, September 2nd. The shares were sold at an average price of $23.35, for a total value of $525,375.00. Following the completion of the transaction, the insider owned 6,504,133 shares in the company, valued at $151,871,505.55. The trade was a 0.34% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Large shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

Squadron Capital Llc also recently made the following trade(s):

• On Friday, August 28th, Squadron Capital Llc sold 326,700 shares of OrthoPediatrics stock. The stock was sold at an average price of $23.04, for a total value of $7,527,168.00.
• On Tuesday, September 1st, Squadron Capital Llc sold 10,131 shares of OrthoPediatrics stock. The stock was sold at an average price of $23.10, for a total value of $234,026.10.
• On Wednesday, August 26th, Squadron Capital Llc sold 18,000 shares of OrthoPediatrics stock. The shares were sold at an average price of $24.28, for a total value of $437,040.00.
• On Tuesday, August 25th, Squadron Capital Llc sold 16,300 shares of OrthoPediatrics stock. The shares were sold at an average price of $24.74, for a total value of $403,262.00.
• On Monday, August 24th, Squadron Capital Llc sold 4,000 shares of OrthoPediatrics stock. The stock was sold at an average price of $25.75, for a total value of $103,000.00.

OrthoPediatrics Stock Performance

Shares of NASDAQ:KIDS opened at $22.41 on Friday. The company has a current ratio of 4.78, a quick ratio of 2.17 and a debt-to-equity ratio of 0.28. OrthoPediatrics Corp. has a 1-year low of $14.42 and a 1-year high of $26.74. The stock has a market capitalization of $585.13 million, a P/E ratio of -13.34 and a beta of 0.99. The business has a 50-day moving average price of $21.78 and a two-hundred day moving average price of $18.87.

OrthoPediatrics (NASDAQ:KIDS) last issued its earnings results on Tuesday, August 4th. The company reported ($0.26) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.30) by $0.04. OrthoPediatrics had a negative net margin of 15.72% and a negative return on equity of 8.10%. The company had revenue of $70.51 million for the quarter, compared to analyst estimates of $68.21 million. Equities analysts predict that OrthoPediatrics Corp. will post -1.14 earnings per share for the current year.

Hedge Funds Weigh In On OrthoPediatrics

Institutional investors have recently modified their holdings of the business. California State Teachers Retirement System grew its position in shares of OrthoPediatrics by 397.1% in the 2nd quarter. California State Teachers Retirement System now owns 4,553 shares of the company’s stock valued at $87,000 after purchasing an additional 3,637 shares during the period. Nantahala Capital Management LLC acquired a new position in shares of OrthoPediatrics in the second quarter valued at approximately $4,636,002. Grandeur Peak Global Advisors LLC acquired a new position in shares of OrthoPediatrics in the second quarter valued at approximately $954,000. Bank of America Corp DE bought a new stake in shares of OrthoPediatrics during the second quarter worth $268,000. Finally, AWM Investment Company Inc. bought a new stake in shares of OrthoPediatrics during the second quarter worth $4,537,000. Institutional investors own 69.05% of the company’s stock.

Wall Street Analysts Forecast Growth

KIDS has been the subject of a number of analyst reports. Truist Financial set a $22.00 target price on shares of OrthoPediatrics in a report on Wednesday, August 5th. TD Cowen reissued a “buy” rating on shares of OrthoPediatrics in a research note on Monday, June 15th. BTIG Research raised their price target on OrthoPediatrics from $24.00 to $29.00 and gave the stock a “buy” rating in a research report on Thursday, August 20th. Weiss Ratings raised OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, August 5th. Finally, Needham & Company LLC upped their price objective on OrthoPediatrics from $30.00 to $35.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. Nine analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, OrthoPediatrics currently has a consensus rating of “Moderate Buy” and a consensus target price of $26.44.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.